News
An entire brain-machine interface on a chip
Researchers from EPFL have developed a next-generation miniaturized brain-machine interface capable of direct brain-to-text communication on tiny silicon chips. Brain-machine interfaces (BMIs) have emerged as a promising solution for restoring communication and control to individuals with severe motor impairments. Traditionally, these systems have been bulky, power-intensive, and limited in their practical applications. Researchers…
Read MoreATREON awarded first InnoDIGITAL grant
ATREON is the first startup to benefit from PACTT’s new InnoDIGITAL programme, worth CHF 40’000, for the development of an innovative monitoring and management tool for patients suffering from inflammatory arthritis. Earlier this year, ATREON and the PACTT (Technology Transfer Office of the CHUV and UNIL) put in place the licensing terms for…
Read MoreWhat is Series: Swiss Biotech Center
Discover the Swiss Biotech Center, a leading research and development center in the field of biotechnology, in GGBa’s “What is Series”. With its modern facilities and state-of-the-art technologies, Swiss Biotech Center (SBC) is a major player in the promotion of innovation and development of new products and technologies in the field of…
Read MoreSOPHIA DDM™ plateform certified under IVDR
SOPHiA GENETICS, the healthcare technology company and a global leader in data-driven medicine, announced that its SOPHiA DDM™ Platform is now CE marked under the European Union’s In Vitro Diagnostic Regulation (IVDR). IVDR certification is a significant regulatory milestone that validates the powerful analytical capabilities of the SOPHiA DDM™ Platform and allows customers…
Read MoreVandria secures $30.7 Million in Series A funding
Vandria secures $30.7 Million in Series A funding to advance groundbreaking mitophagy therapies. The Vaud-based company announced the second closing of its Series A financing, bringing the final amount raised to date to $30.7 Million (CHF 28.3 Million). Vandria welcomes new institutional investors Hevolution Foundation and Dolby Family Ventures, who have joined its…
Read MoreCSEM announced Andrea Dunbar as new CTO
CSEM announced the appointment of Andrea Dunbar as the new Chief Technology Officer (CTO), effective January 2025. Dunbar will succeed Harry Heinzelmann, who will retire on January 31, 2025, after an esteemed 27-year career with CSEM. Andrea Dunbar joined CSEM in 2007 as a physicist and scientist and has successfully driven innovation, particularly…
Read MoreBiopôle CEO interview with FutureHealth
Biopôle CEO, Nasri Nahas, talks innovation, disruptive models and technology ahead of FutureHealth Lausanne. Mr Nahas, how is Biopôle positioning itself in the Swiss innovation market and, looking ahead over the next five years, what specific goals are you pursuing? Innovation is not only about great ideas, it is about bringing those ideas…
Read MoreEPFL has developed a new AI approach to protein design
EPFL researchers have developed a novel AI-driven model designed to predict protein sequences from backbone scaffolds, incorporating complex molecular environments. It promises significant advancements in protein engineering and applications across various fields, including medicine and biotechnology. Designing proteins that can perform specific functions involves understanding and manipulating their sequences and structures. This task…
Read MoreRelease Therapeutics secures CHF 3.3 Million in seed funding
The Campus Biotech-based BioMedTech company announced the closure of a CHF 3.3 Million Seed financing round with private investors. The financing follows the Company’s first preclinical results in animal models of metachromatic leukodystrophy (MLD). MLD is a rare genetic disorder of the nervous system stemming from a deficiency in the lysosomal enzyme, arylsulfatase…
Read MoreSamanTree Medical raises $14 Million in Series B financing round
SamanTree Medical, a leading medical technology company specialising in innovative solutions to improve the outcomes of surgery, announced the closing of $14 Million as part of a Series B financing round. The new capital will be used to further develop and commercialise the Histolog® Scanner, expand its reach in Europe and the United…
Read More